Autobio Diagnostics Co., Ltd. (SHA:603658)

Autobio Diagnostics Revenue

Autobio Diagnostics had revenue of 1.18B CNY in the quarter ending September 30, 2026, with 10.76% growth. This brings the company's total for the last twelve months to 4.34B, up 2.86% year-over-year. In the year 2025, Autobio Diagnostics had annual revenue of 4.23B, down -5.47%. That makes Autobio Diagnostics the 9,810th largest company in the world by revenue and 1,582nd in China.

• Revenue (ttm): 4.34B
• Revenue Growth: +2.86%
• P/S Ratio: 5.04
• Revenue / Employee: 761.19K
• Employees: 5,700
• Market Cap: 21.89B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 3.76B 90.7%
• Overseas 383.78M 9.3%

Fiscal year ended Dec 31, 2025 See the full Autobio Diagnostics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.23B	-244.79M	-5.47%
Dec 31, 2024	4.47B	27.55M	0.62%
Dec 31, 2023	4.44B	2.03M	0.05%
Dec 31, 2022	4.44B	675.71M	17.94%
Dec 31, 2021	3.77B	787.79M	26.45%

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error